Efficacy & Safety of Co-administration of Psychedelics with Psychiatric Medications
Pharmacy Times interviewed Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, on his recent presentations at Insight 2021 and the virtual Sana Symposium on psychedelic adverse effects and drug-drug interactions.
Alana Hippensteele: What are some key points to consider regarding co-administration of the psychedelics with psychiatric medications?
Kelan Thomas: Yeah, so the main things to consider are, even though MDMA have these sort of theoretical
risks, when they looked at studies of healthy volunteers who were taking MDMA and
then previously were given SSRIs or SNRI antidepressants, it actually attenuates the
blood pressure effects, which demonstrates to me that there's sort of a pharmacodynamic
interaction at play whereby the SSRIs are actually preventing some of the uptake of
MDMA into the pre-synapse. So, it's not having as big of an effect on heart rate and
blood pressure in co-administration.
Copyright 2005 - 2020, Touro University, All Rights Reserved.